Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer
NCT ID: NCT04478669
Last Updated: 2022-02-17
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Total Enrollment
250 participants
Study Classification
OBSERVATIONAL
Study Start Date
2020-09-17
Study Completion Date
2022-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The challenge of breast conserving surgery (BCS) is to obtain free resection margins, by removing the invasive tumor and the precursor cells: DCIS (Ductal Carcinoma in Situ). Consequently, 17%-25% of primary invasive breast cancer patients will need a repeat surgery. Repeat breast surgery has been associated with higher surgical risks, poorer cosmetic outcome and increased psychological and economic burden. Finding a precise method to obtain tumor- and DCIS-free resection margins during BCS is therefore strongly needed.
The purpose with this study is to investigate if the need for a re-operation can be reduced by performing Digital Breast Tomosynthesis (DBT) of the resected tumor margins compared to the currently used standard X-ray during BCS.
The purpose with this study is to investigate if the need for a re-operation can be reduced by performing Digital Breast Tomosynthesis (DBT) of the resected tumor margins compared to the currently used standard X-ray during BCS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digital Breast Tomosynthesis in Younger Symptomatic Women
NCT01241981
Breast Cancer
COMPLETED
Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women
NCT02209129
Breast Cancer
UNKNOWN
Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer
NCT03190083
Breast Cancer
COMPLETED
NA
Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging
NCT01060085
Ductal Carcinoma In Situ
Invasive Breast Cancer
COMPLETED
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
NCT04797299
DCIS
RECRUITING
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background Breast cancer is the most common type of cancer in Denmark with approximately 4700 new cases each year, with an increased incidence during the last decades. Almost 70% of the patients are treated with breast conserving surgery (BCS) and breast irradiation. Unfortunately, 5.9 % of the patients treated with BCS will experience local recurrence after 9 years. The strongest predictor for local recurrence is a positive pathologic resection margin. Therefore it is important intraoperatively to be able to evaluate the margin width of the resected specimen precisely. The challenge during BCS is to remove the primary invasive breast cancer, with negative resection margin, free of invasive tumor and DCIS, Ductal Carcinoma In Situ. Some have concluded that lack of accurate imaging especially of the DCIS is the main reason for positive margins and repeat surgery, as the DCIS often, but not in all cases, contains microcalcifications that can be detected on mammography (x-ray of the breast). Consequently, 17%-25% of the patients will need a second or a third surgery. Repeat surgery has been associated with higher surgical risk, poorer cosmetic outcome, and increased psychological and economic burden for both patients and the society. Finding an optimal imaging method to obtain adequate resection margins close to or during BCS that can reduce the number of repeat surgeries, is therefore strongly needed.
Definition of resection margin status
A safe macroscopic surgical resection margin is, according to the Danish Breast Cancer Group´s (DBCG) guidelines, defined as a margin width ≥ 5mm minimizing the risk of leaving residual tumor. In many institutions in Denmark, a perioperative evaluation of the tumor is performed as a macroscopically assessment by a pathologist. This is a ressource demanding procedure and X-ray of the specimen is used instead. A radiological, positive resection margin is defined as a margin width of 0 mm, that leads to a re-excision during the same surgical procedure, and additional breast tissue is removed at the exact same area of the patient's breast. This procedure aims to avoid the discomfort of a repeat surgery. The perioperative radiological assessment of the resection margins is afterwards confirmed microscopically, where a positive margin at our institution is defined as "tumor on ink", meaning tumor cells in the inked resection margin with 0 mm to the margin. A positive margin will trigger a repeat surgery, either a new BCS or a mastectomy where the whole breast is removed. For DCIS, a margin-width of less than 2 mm is considered positive, and the patient will be offered repeat surgery according to guidelines. A distance from the invasive carcinoma to the resection margin of \< 2 mm, but not "on the ink" is surgical considered sufficient and the patient will according to DBCG guidelines, not require a repeat surgery, but will instead be offered additional boost to the subsequent radiotherapy. The result of the final histopathology is, however, not available until 7 workdays after the initial BCS. Guidance of a more optimal perioperative methods to evaluate the resection margins during BCS would, therefore, be highly desirable, and could potentially lead to a decreased rate of repeat surgery and hence save several patients from the discomfort of a second surgical procedure.
Intraoperative imaging methods for margin assessment
Various methods to assess resection margins have been investigated such as frozen section analysis, imprint cytology, macroscopically evaluation and imaging with x-ray, micro-CT scanning or ultrasound of the resected tumor margins. All have, however, their limitations, either because they are time consuming, or simply because they are not accurate enough to predict resection margin status. The imaging modality X-ray has been reported in several studies to have a high specificity, predicting negative margins up to 95%, but unfortunately a low sensitivity of only 21%. That means that the method is particularly good to predict a negative margin. The X-ray is less sensitive when it comes to predict a positive resection margin, with the final histopathology as a reference method. The lower sensitivity is due to the fact, that x-ray has difficulties, when it comes to detect the breast tumor in a very dense normal breast tissue, most common for young women. The X-ray evaluation also has the disadvantage of only delivering a 2D solution to a 3D problem. The other imaging method currently in use is ultrasound that has a high sensitivity of 80% but a low specificity of 59% to predict positive resection margins (Ramos M. et al).
A new method called Micro-CT (micro-Computed Tomography) can provide 3D imaging of the resected tumor and the microcalcifications that helps to asses all margins of the resected tumor. Unfortunately, there is a high interobserver variability reported with this method. Furthermore, it is difficult to differentiate between tumor and normal breast tissue in the resected margins in some of the cases, which makes it impossible for the radiologist to determine if the margins are positive or negative. This may be one of the reasons for, why this method does not perform so well with a sensitivity range of only 38%-56%.
Digital Breast Tomosynthesis (DBT) is a novel method for assessment of resection margins based on X-ray technology. DBT provides images of the resected tumor with a large field of view of the specimen and a high resolution, that allows the radiologist to examine the resected specimen in one millimeter increments both in 2D and 3D, where the extent and the shape of the tumor and the microcalcifications are better defined than on conventional 2D mammography. Only few clinical studies have investigated DBT for evaluation of resection margins with the most recent study with 98 patients included (Park KU. et al). This study reported a high performance of the DBT with a sensitivity to predict positive margins of 93%, and a specificity of 78%, to predict negative margins, with the final histopathology as a reference method.
Objectives
The overall objective of the present study is to investigate if adequate resection margins can be obtained with use of DBT of the resected margins during BCS to reduce the rate of repeat surgery and avoid further unnecessary complications and psychological stress for the patients.
Hypothesis
Does intraoperative DBT improve assessment of the resected margins compared to standard method with X-ray? The final histopathology will be used as a reference method.
1. DBT can contribute to obtain negative resection margins and thereby reduce the need of repeat surgery as compared to X-ray.
2. The performance of DBT predicting resection margin status is more accurate compared to the standard method with X-ray.
Study participants
The study participants will be recruited at the Department of Plastic and Breast Surgery at Aarhus University Hospital after they have been diagnosed with operable invasive breast cancer and scheduled for BCS. The study participants will receive separate information leaflet about this project that respects the applicable regulatory requirements. The page describing the rights of the patient participating in a health research project will also be handed out to the patient by the breast surgeon. The breast surgeon will obtain the informed consent from the patient and mention in the patient's medical record, that the patient has given consent to participate in this project.
Randomization
The study participant will be randomized to either the DBT or the standard method (X-ray) by the breast surgeon in the system REDCap®. REDCap® is a secure web platform that can build and manage online databases and surveys that will also be used for the data management of this project. The randomization will be performed by the breast surgeon during the first consultation with the patient, as soon as the patient has given oral and written consent and is included in each trial.
Handling of the resected breast tumor
The study encompasses tissue being procured as part of the normal diagnostic procedure. The material will, as all tissue collected for diagnostic purposes, be kept in the existing clinical biobank at the Department of Pathology, at Aarhus University Hospital during as well as after the closure of the study. A research biobank will therefore not be established
Safety
There are no side effects and no risk of radiation for the investigators in the DBT-trial, as the resected tumor will be located inside the DBT or in the X-ray that is a closed system, ex-vivo, with no radiation exposure to the technical staff or to the study patients.
Statistics and analysis
A sample size of 123 study participants was calculated as necessary to detect a reduction from 20% in the X-ray-group to 7% in the DBT-group with a statistical power of 80% and a 5% level of significance. The investigators expect a few patients may drop-out for different reasons, and estimated that a total number of 250 patients are enough to be included in the DBT-trial.
The statistical analyses and calculation will be made primarily by the investigator Irina Palimaru Manhoobi (IPM) using STATA® where after the work will be reviewed by a statistician to ensure a high quality of the statistical work.
1. The occurrence of positive resections margins, re-excisions and repeat surgery will be compared between groups using the Fisher exact test.
2. The performance of the tested and the standard method: The sensitivity, specificity, Positive Predictive Value (PPV) and the Negative Predictive Value (NPV) compared to the reference method will be calculated with the McNemar Chi-Square test.
A two-sided p-value of less than 0.05 will be considered statistically significant.
Data management
The study participants will be identified from the Central Personal Register system (CPR) with permission obtained the 1st of April 2020 from the Danish Data Protection Agency (DDPA) / "Region Midtjyllands interne fortegnelse over forskningsprojekter" with case number 1-16-02-141-20. The informed consent from all study participants gives the investigator, sponsor and the representants of the sponsor, the direct access to the below described clinical data from the medical record (EPJ) Electronical Patient Journal, that is important to perform this project. All clinical data will be transferred anonymously to the secure web application for data management in "RedCap" that is administered by Aarhus University. The investigator IPM is responsible for the data management. The study is in according to the guidelines of the Helsinki Declaration II, GCP guidelines and the Danish Legislation regarding clinical trials and legislation regarding personal data.
Definition of resection margin status
A safe macroscopic surgical resection margin is, according to the Danish Breast Cancer Group´s (DBCG) guidelines, defined as a margin width ≥ 5mm minimizing the risk of leaving residual tumor. In many institutions in Denmark, a perioperative evaluation of the tumor is performed as a macroscopically assessment by a pathologist. This is a ressource demanding procedure and X-ray of the specimen is used instead. A radiological, positive resection margin is defined as a margin width of 0 mm, that leads to a re-excision during the same surgical procedure, and additional breast tissue is removed at the exact same area of the patient's breast. This procedure aims to avoid the discomfort of a repeat surgery. The perioperative radiological assessment of the resection margins is afterwards confirmed microscopically, where a positive margin at our institution is defined as "tumor on ink", meaning tumor cells in the inked resection margin with 0 mm to the margin. A positive margin will trigger a repeat surgery, either a new BCS or a mastectomy where the whole breast is removed. For DCIS, a margin-width of less than 2 mm is considered positive, and the patient will be offered repeat surgery according to guidelines. A distance from the invasive carcinoma to the resection margin of \< 2 mm, but not "on the ink" is surgical considered sufficient and the patient will according to DBCG guidelines, not require a repeat surgery, but will instead be offered additional boost to the subsequent radiotherapy. The result of the final histopathology is, however, not available until 7 workdays after the initial BCS. Guidance of a more optimal perioperative methods to evaluate the resection margins during BCS would, therefore, be highly desirable, and could potentially lead to a decreased rate of repeat surgery and hence save several patients from the discomfort of a second surgical procedure.
Intraoperative imaging methods for margin assessment
Various methods to assess resection margins have been investigated such as frozen section analysis, imprint cytology, macroscopically evaluation and imaging with x-ray, micro-CT scanning or ultrasound of the resected tumor margins. All have, however, their limitations, either because they are time consuming, or simply because they are not accurate enough to predict resection margin status. The imaging modality X-ray has been reported in several studies to have a high specificity, predicting negative margins up to 95%, but unfortunately a low sensitivity of only 21%. That means that the method is particularly good to predict a negative margin. The X-ray is less sensitive when it comes to predict a positive resection margin, with the final histopathology as a reference method. The lower sensitivity is due to the fact, that x-ray has difficulties, when it comes to detect the breast tumor in a very dense normal breast tissue, most common for young women. The X-ray evaluation also has the disadvantage of only delivering a 2D solution to a 3D problem. The other imaging method currently in use is ultrasound that has a high sensitivity of 80% but a low specificity of 59% to predict positive resection margins (Ramos M. et al).
A new method called Micro-CT (micro-Computed Tomography) can provide 3D imaging of the resected tumor and the microcalcifications that helps to asses all margins of the resected tumor. Unfortunately, there is a high interobserver variability reported with this method. Furthermore, it is difficult to differentiate between tumor and normal breast tissue in the resected margins in some of the cases, which makes it impossible for the radiologist to determine if the margins are positive or negative. This may be one of the reasons for, why this method does not perform so well with a sensitivity range of only 38%-56%.
Digital Breast Tomosynthesis (DBT) is a novel method for assessment of resection margins based on X-ray technology. DBT provides images of the resected tumor with a large field of view of the specimen and a high resolution, that allows the radiologist to examine the resected specimen in one millimeter increments both in 2D and 3D, where the extent and the shape of the tumor and the microcalcifications are better defined than on conventional 2D mammography. Only few clinical studies have investigated DBT for evaluation of resection margins with the most recent study with 98 patients included (Park KU. et al). This study reported a high performance of the DBT with a sensitivity to predict positive margins of 93%, and a specificity of 78%, to predict negative margins, with the final histopathology as a reference method.
Objectives
The overall objective of the present study is to investigate if adequate resection margins can be obtained with use of DBT of the resected margins during BCS to reduce the rate of repeat surgery and avoid further unnecessary complications and psychological stress for the patients.
Hypothesis
Does intraoperative DBT improve assessment of the resected margins compared to standard method with X-ray? The final histopathology will be used as a reference method.
1. DBT can contribute to obtain negative resection margins and thereby reduce the need of repeat surgery as compared to X-ray.
2. The performance of DBT predicting resection margin status is more accurate compared to the standard method with X-ray.
Study participants
The study participants will be recruited at the Department of Plastic and Breast Surgery at Aarhus University Hospital after they have been diagnosed with operable invasive breast cancer and scheduled for BCS. The study participants will receive separate information leaflet about this project that respects the applicable regulatory requirements. The page describing the rights of the patient participating in a health research project will also be handed out to the patient by the breast surgeon. The breast surgeon will obtain the informed consent from the patient and mention in the patient's medical record, that the patient has given consent to participate in this project.
Randomization
The study participant will be randomized to either the DBT or the standard method (X-ray) by the breast surgeon in the system REDCap®. REDCap® is a secure web platform that can build and manage online databases and surveys that will also be used for the data management of this project. The randomization will be performed by the breast surgeon during the first consultation with the patient, as soon as the patient has given oral and written consent and is included in each trial.
Handling of the resected breast tumor
The study encompasses tissue being procured as part of the normal diagnostic procedure. The material will, as all tissue collected for diagnostic purposes, be kept in the existing clinical biobank at the Department of Pathology, at Aarhus University Hospital during as well as after the closure of the study. A research biobank will therefore not be established
Safety
There are no side effects and no risk of radiation for the investigators in the DBT-trial, as the resected tumor will be located inside the DBT or in the X-ray that is a closed system, ex-vivo, with no radiation exposure to the technical staff or to the study patients.
Statistics and analysis
A sample size of 123 study participants was calculated as necessary to detect a reduction from 20% in the X-ray-group to 7% in the DBT-group with a statistical power of 80% and a 5% level of significance. The investigators expect a few patients may drop-out for different reasons, and estimated that a total number of 250 patients are enough to be included in the DBT-trial.
The statistical analyses and calculation will be made primarily by the investigator Irina Palimaru Manhoobi (IPM) using STATA® where after the work will be reviewed by a statistician to ensure a high quality of the statistical work.
1. The occurrence of positive resections margins, re-excisions and repeat surgery will be compared between groups using the Fisher exact test.
2. The performance of the tested and the standard method: The sensitivity, specificity, Positive Predictive Value (PPV) and the Negative Predictive Value (NPV) compared to the reference method will be calculated with the McNemar Chi-Square test.
A two-sided p-value of less than 0.05 will be considered statistically significant.
Data management
The study participants will be identified from the Central Personal Register system (CPR) with permission obtained the 1st of April 2020 from the Danish Data Protection Agency (DDPA) / "Region Midtjyllands interne fortegnelse over forskningsprojekter" with case number 1-16-02-141-20. The informed consent from all study participants gives the investigator, sponsor and the representants of the sponsor, the direct access to the below described clinical data from the medical record (EPJ) Electronical Patient Journal, that is important to perform this project. All clinical data will be transferred anonymously to the secure web application for data management in "RedCap" that is administered by Aarhus University. The investigator IPM is responsible for the data management. The study is in according to the guidelines of the Helsinki Declaration II, GCP guidelines and the Danish Legislation regarding clinical trials and legislation regarding personal data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Invasive Breast Cancer
Mastectomy, Segmental
Margins of Excision
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
OTHER
Study Time Perspective
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed women with biopsy-verified invasive breast cancer planned for breast conserving surgery.
* Age \> 18 year
* Age \> 18 year
Exclusion Criteria
* Previous surgery for pre-malignant or malignant lesions in the breast
* Planned mastectomy
* Planned mastectomy
Minimum Eligible Age
19 Years
Eligible Sex
FEMALE
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Irina Palimaru Manhoobi
MD, PhD student, radiologist
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peer Christiansen, DMSc, Prof.
Role: PRINCIPAL_INVESTIGATOR
Department of Plastic and Breast Surgery, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department og Plastic- and Breast Surgery
Aarhus, Danmark, Denmark
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Denmark
References
Explore related publications, articles, or registry entries linked to this study.
Amiel CR, Fisher HM, Carver CS, Antoni MH. The importance of stress management among postresection breast cancer patients. Future Oncol. 2016 Dec;12(24):2771-2774. doi: 10.2217/fon-2016-0442. Epub 2016 Oct 19. No abstract available.
Reference Type
BACKGROUND
DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation. Ann Surg Oncol. 2018 Oct;25(10):2965-2974. doi: 10.1245/s10434-018-6580-9. Epub 2018 Jul 9.
Reference Type
BACKGROUND
Thill M, Baumann K, Barinoff J. Intraoperative assessment of margins in breast conservative surgery--still in use? J Surg Oncol. 2014 Jul;110(1):15-20. doi: 10.1002/jso.23634. Epub 2014 May 24.
Reference Type
BACKGROUND
Bodilsen A, Bjerre K, Offersen BV, Vahl P, Amby N, Dixon JM, Ejlertsen B, Overgaard J, Christiansen P. Importance of margin width in breast-conserving treatment of early breast cancer. J Surg Oncol. 2016 May;113(6):609-15. doi: 10.1002/jso.24224. Epub 2016 Mar 16.
Reference Type
RESULT
Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):979-85. doi: 10.1016/s0360-3016(03)00740-5.
Reference Type
RESULT
Jeevan R, Cromwell DA, Trivella M, Lawrence G, Kearins O, Pereira J, Sheppard C, Caddy CM, van der Meulen JH. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012 Jul 12;345:e4505. doi: 10.1136/bmj.e4505.
Reference Type
RESULT
Bodilsen A, Bjerre K, Offersen BV, Vahl P, Ejlertsen B, Overgaard J, Christiansen P. The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S476-85. doi: 10.1245/s10434-015-4707-9. Epub 2015 Jul 16.
Reference Type
RESULT
McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, Engel JM, Onitilo AA. Variability in reexcision following breast conservation surgery. JAMA. 2012 Feb 1;307(5):467-75. doi: 10.1001/jama.2012.43.
Reference Type
RESULT
Hisada T, Sawaki M, Ishiguro J, Adachi Y, Kotani H, Yoshimura A, Hattori M, Yatabe Y, Iwata H. Impact of intraoperative specimen mammography on margins in breast-conserving surgery. Mol Clin Oncol. 2016 Sep;5(3):269-272. doi: 10.3892/mco.2016.948. Epub 2016 Jul 4.
Reference Type
RESULT
Ramos M, Diaz JC, Ramos T, Ruano R, Aparicio M, Sancho M, Gonzalez-Orus JM. Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer. Breast. 2013 Aug;22(4):520-4. doi: 10.1016/j.breast.2012.10.006. Epub 2012 Oct 27.
Reference Type
RESULT
McClatchy DM 3rd, Zuurbier RA, Wells WA, Paulsen KD, Pogue BW. Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology. Breast Cancer Res Treat. 2018 Dec;172(3):587-595. doi: 10.1007/s10549-018-4951-3. Epub 2018 Sep 17.
Reference Type
RESULT
Park KU, Kuerer HM, Rauch GM, Leung JWT, Sahin AA, Wei W, Li Y, Black DM. Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery. Ann Surg Oncol. 2019 Jun;26(6):1720-1728. doi: 10.1245/s10434-019-07226-w. Epub 2019 Mar 14.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1107210020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial
NCT01524029
UNKNOWN
Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense Breasts
NCT01910103
COMPLETED
Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography
NCT01593384
WITHDRAWN
HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
NCT02095210
TERMINATED
PHASE1
National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations
NCT00413491
UNKNOWN
PHASE4
Early Detection of Breast Cancer Using Tomosynthesis Imaging
NCT00637598
COMPLETED
NA
The Effect of Digital Breast Tomosynthesis in Breast Cancer Long-term Survival: a Single Institution Study
NCT05600257
COMPLETED
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
NCT01372631
COMPLETED
NA
The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
NCT06854887
NOT_YET_RECRUITING
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189
COMPLETED
Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT
NCT01552655
COMPLETED
NA
Study First Step to Virtual Breast Cancer Localization
NCT03214419
COMPLETED
Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
NCT02766881
COMPLETED
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
NCT06217458
NOT_YET_RECRUITING
NA
Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
NCT01086514
COMPLETED
NA
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
NCT03176979
COMPLETED
NA
Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients
NCT02688725
UNKNOWN
NA
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346
TERMINATED
PHASE3
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
NCT02313116
SUSPENDED
Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy
NCT05951699
RECRUITING
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT05056818
RECRUITING
Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy
NCT00535184
COMPLETED
Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy
NCT04498611
COMPLETED
NA
Community Hospital Identification of High CV Risk Patients During Cancer Treatment
NCT02566109
TERMINATED
NA